Bio-Techne (formerly Lunaphore) has announced a strategic partnership between its spatial biology brand Lunaphore and the Wyss Center Geneva to…

DigeHealth SA, a Swiss medtech company developing a wearable device that “listens to the gut” to support early detection and…

Led by Isa Dupont, a nurse, and Gaspard Chevassus, an engineer, the StudentsPool project is reinventing ad hoc recruitment and…

EspeRare, a pioneering Geneva-based nonprofit biotech, announced that it has been awarded a Grand Challenges grant from the Gates Foundation….

Testmate Health and Intermountain Health have announced a strategic partnership and investment to accelerate access to rapid, low-cost molecular tests…

The clinic group is soon to be acquired by the Geneva-based shipping giant. The restructuring is expected to be completed by the end of 2026.

This new center is designed to accelerate the development of neuromodulation technologies for psychiatric and neurological disorders.

On World AIDS Day 2025, the International AIDS Society (IAS) and Geneva University Hospitals (HUG) announced that Geneva has been…

Valais-based Pacrim Group has taken a major strategic step in the Swiss life-science landscape by acquiring a controlling majority of Medropharm AG, a pioneer in pharmaceutical-grade cannabis. Announced on 21 October 2025, the transaction positions Pacrim — together with its subsidiary Alponics SA — as Switzerland’s only fully integrated medicinal cannabis enterprise, spanning the entire value chain from plant genetics to patient-ready products.

Japonese company Takeda has reached an important milestone in Western Switzerland with the inauguration of a new aseptic filling facility…

Artiria Medical, an EPFL spinoff and Swiss innovator in neurovascular technologies, announces that its SmartGUIDE™ 014 deflectable guidewire, a next-generation…

Cell and gene therapies are promising, but remain extremely expensive. The pharmaceutical company Bracco Imaging, a leader in medical imaging,…